General Information
Product name
Erythromycin Estolate
CAS No.
3521-62-8
Icons in SDS
Company Information
company name
Central Drug House (P) Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
care@cdhfinechemical.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H317, H334
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
CLP CLASSIFICATION
Acute toxicity, Oral (Category 4), H302 Respiratory sensitisation (Category 1), H334 Skin sensitisation (Category 1), H317 For the full text of the H-Statements mentioned in this Section, see Section 16.
2.2 Label elements
Labelling according Regulation (EC) No 1272/2008
Signal word
Danger
Hazard statements
H302 Harmful if swallowed. H317 May cause an allergic skin reaction. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Precautionary statements
P261 Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray. P280 Wear protective gloves. P284 Wear respiratory protection. P301 + P312 + P330 IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER/doctor.
Supplemental label elements
none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
